AIRO 2027 _ Symposium

Dernière mise à jour : 05/11/2026

Bannière visuelle de présentation de la formation
An international scientific symposium exploring innovations and future developments in proton therapy, featuring expert presentations on technological advances, FLASH, dosimetry, quality assurance and multidisciplinary research.

Description

UNICANCER PROTON THERAPY SYMPOSIUM

Friday, March 12, 2027

14:00–16:30 | RATP House – Paris

This international scientific symposium aims to explore the latest innovations and future developments in proton therapy.

Leading international experts will share scientific updates, technological advances and research perspectives.

SYMPOSIUM PROGRAMME

12:30–14:00 | Lunch – Industry Presentations

14:00–14:30 | PTCOG Update: Technological Advances and Emerging European Players

14:30–15:00 | Arc Therapy / FLASH / SFRT

Speaker: Dr Jérôme Doyen MD PhD, radiation oncologist (Centre Antoine Lacassagne, Nice, France)

15:00–15:30 | Patient Quality Assurance, Dosimetry, Monte Carlo and Uncertainty Management

Feedback on ESTRO / EPTN Guidelines 2026

Speaker: Dr Loïc Grevillot PhD, deputy head of medical physics division (MedAustron, Wiener Neustadt, Austria)

15:30–16:00 | Advancing Proton Therapy Through Multidisciplinary Research

Speaker: Dr Sara Marcatili PhD HDR, researcher (CNRS Nuclear and Particles, Paris, France)

16:00–16:30 | Discussion and Closing: Future of Proton Therapy in Europe

Speaker: Dr Pierre-Yves Bondiau MD PhD, radiation oncologist (Centre Antoine Lacassagne, Nice, France)

 

 

REGISTRATION CONDITIONS – COMPLIMENTARY EVENT

Participation in the Unicancer Proton Therapy Symposium is free of charge and exclusively reserved for participants registered for the full 1.5-day AIRO training programme, taking place on March 11 and 12, 2027.

Registration for the AIRO training programme automatically includes registration for the symposium.

A separate confirmation of registration will be sent to participants, including the symposium programme and practical information.

The symposium is a complementary scientific event, separate from the AIRO training programme

Objectifs

The symposium aims to:

  • Explore the latest technological advances and emerging developments in proton therapy

  • Discover innovations in Arc Therapy, FLASH and SFRT

  • Share scientific updates on patient quality assurance, dosimetry and uncertainty management

  • Explore the contribution of multidisciplinary research to proton therapy

  • Discuss future developments and perspectives for proton therapy in Europe

Public visé

Registered participants of the 1.5-day AIRO 2027 training programme, including:

  • Radiation oncologists

  • Medical physicists

  • Dosimetrists

  • RTTs

  • Biomedical engineers

  • Department heads

  • Lawyers

  • Healthcare administrators

  • Healthcare decision-makers

Prérequis

Mandatory condition: Participants must be registered for the full 1.5-day AIRO 2027 training programme (March 11–12, 2027).

The symposium is offered free of charge exclusively to registered AIRO participants.

No separate paid registration is available.

The event will be conducted in English.

Modalités pédagogiques

  • Scientific presentations by international experts
  • Sharing of research findings and professional experience
  • Interactive discussions and exchanges with participants
  • Multidisciplinary scientific discussions

Moyens et supports pédagogiques

Event Resources and Facilities

  • Scientific presentations by international speakers

  • Opportunities for discussion and exchange between participants and experts

  • Conference facilities and audiovisual equipment

Venue

RATP House
54 Quai de la Râpée
75012 Paris, France

Modalités d'évaluation et de suivi

Registration and Attendance

  • Separate registration confirmation sent to participants

  • No placement questionnaire required

  • No assessment of learning outcomes

  • No end-of-course assessment quiz

The symposium is a scientific event and does not form part of the AIRO training programme's educational hours.

Accessibilité pour les personnes en situation de handicap

Accessibility for People with Disabilities

Unicancer Formation has a designated disability officer.
They provide information and support to participants with disabilities and ensure that everyone can access the training under the best possible conditions.

 Contact : David Aubry d-aubry@unicancer.fr

Our trainers are aware of and trained to welcome participants with disabilities.

Unicancer Formation is committed to promoting diversity and inclusion. All applications are reviewed on an equal opportunity basis.

Before the training
Please contact us as early as possible by email at unicancer-formation@unicancer.fr to inform us of any specific needs or accommodations required.
You are welcome to complete the dedicated form questionnaire to help us better prepare your participation

On the Day of the training 

A member of the Unicancer Formation team will welcome you 30 minutes before the start of the session.

During the training

The trainer will implement the accommodation measures previously identified with you before the course.

Accessibility Register
The accessibility register of our training organization is available upon request at unicancer-formation@unicancer.fr.

Support Measures
We invite you to explore the support and assistance measures we offer, available by clicking the link below ici.

Délais d'accès

Registration deadline: 4 March 2027

Registration is open until 7 days before the start of the training, subject to availability.

For any questions regarding registration:
unicancer-formation@unicancer.fr

Tarif

Organisational Features

  • Complimentary participation for registered AIRO participants

  • Transport and accommodation at participants' expense

Accessibility

Accessible to people with disabilities.

For any specific request, please contact our disability officer.

Profil du / des Formateur(s)

The symposium brings together international experts recognised for their scientific and clinical expertise in proton therapy.

Speakers include radiation oncologists, medical physicists and researchers specialising in technological innovation, dosimetry, quality assurance and multidisciplinary research.

Scientific Coordinators

  • Dr Pierre-Yves Bondiau MD PhD – Radiation Oncologist

  • Pr Arnaud Beddok MD PhD – Full Professor of Radiation Oncology

Inscription

Ajouter au panier

Session sélectionnée

  • COMPLÈTE

Prochaines Sessions

  • Désolé, cette formation n'est pas programmée pour le moment.

    Si vous êtes responsable formation, vous pouvez faire une requête pour l'organiser en INTRA dans votre entreprise.

Partager cette formation

Indicateurs de performance d'Unicancer Formation 

96% de nos apprenants ont été satisfaits ou très satisfaits de la formation en 2025

97% de nos apprenants ont été satisfaits ou très satisfaits des formateurs en 2025

98% de nos apprenants considèrent que les compétences acquises lors de nos formations s’appliquent dans l’environnement du travail en 2025

96% de nos apprenants ont suivi l'entièreté de leur parcours de formation en 2025

Nombre d'apprenants formés en 2025 : 411

 

Si vous désirez nous transmettre une réclamation, vous pouvez nous l'adresser par mail à unicancer-formation@unicancer.fr

 

Accessibilité

Sélectionnez le niveau de contraste souhaité
Réduisez les animations
Adaptez la taille de la police
Sélectionnez la police de caractères souhaitée

Déclaration d'accessibilité